Blood test with 14-protein signature predicts lung cancer years in advance

Lung cancer affects 2.5 million people annually with 1.8 million deaths worldwide, making early detection potentially life-saving for at-risk populations.

Each year, lung cancer quietly claims nearly two million lives — most of them in people who had no warning until it was too late. A team of scientists at the Francis Crick Institute in London has now identified a 14-protein signature in blood plasma that can detect who will develop the disease up to five years before diagnosis, offering, for the first time, a credible biological window for prevention. The discovery also points toward an existing anti-inflammatory drug as a possible shield against the disease — a reminder that medicine sometimes finds its answers in unexpected places. The road

Blood test with 14-protein signature predicts lung cancer years in advance

Cobertura Relacionada

Receba o Register no seu e-mail